| Keywords: |
cancer survival; cancer surgery; clinical trial; review; nonhuman; animal; melanoma; pain; gene expression; nausea; vomiting; myalgia; cytotoxicity; fever; sarcoma; immunology; chemistry; statistical analysis; immunotherapy; cancer vaccine; neuroblastoma; immunogenicity; cell membrane; erythema; immunological adjuvant; vaccine production; adjuvants, immunologic; astrocytoma; lipid bilayer; antibody titer; keyhole limpet hemocyanin; complement; immunoglobulin m antibody; hemocyanin; glycosphingolipid; gangliosides; ganglioside; active immunization; mollusc; immunotherapy, active; human; priority journal; keyhole-limpet hemocyanin; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; mollusca
|
